Current evidence, including magnetic resonance imaging studies, suggests that skeletal muscle alterations resulting from GLP-1 RA-induced weight loss, such as enhanced insulin sensitivity and reduced muscle fat infiltration, are adaptive, thereby improving muscle quality despite concurrent reductions in lean mass [112]
This article takes a deep dive into the science, safety data (or lack thereof), legal status, and ethical implications of using BPC-157
& Mulvihill, S
Since the injection only needs to be taken once per week, it has been accepted well by patients who need long-term treatment for metabolic disorders
Tirzepatide is also a GLP-1RA, but it is also a Gastric Inhibitory Peptide (GIP), so it essentially binds even more receptors than semaglutide, and thus more potently suppresses appetite
lacks rigorous scientific support